P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.

MLA

Papavassiliou, Kostas A., et al. “P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.” International Journal of Molecular Sciences, vol. 25, no. 5, Mar. 2024, p. 2479. EBSCOhost, https://doi.org/10.3390/ijms25052479.

APA

Papavassiliou, K. A., Sofianidi, A. A., Gogou, V. A., Anagnostopoulos, N., & Papavassiliou, A. G. (2024). P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation. International Journal of Molecular Sciences, 25(5), 2479. https://doi.org/10.3390/ijms25052479

Chicago

Papavassiliou, Kostas A., Amalia A. Sofianidi, Vassiliki A. Gogou, Nektarios Anagnostopoulos, and Athanasios G. Papavassiliou. 2024. “P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.” International Journal of Molecular Sciences 25 (5): 2479. doi:10.3390/ijms25052479.